STOCKHOLDERS' EQUITY AND STOCK-BASED COMPENSATION - (Tables)

6 Months Ended

Sep. 30, 2025

Equity [Abstract]

Schedule of Stock-based Compensation Activity, by Award Type

The Company's stock-based compensation activity for the six months ended September 30, 2025 and 2024, by award type, was (dollars in thousands):

	For the six months ended
	September 30,
	2025		2024
Stock options	$	1,260	$	1,639
Restricted stock units, time-vesting	31,751		43,929
Restricted stock units, performance-based	9,113		7,121
Habu restricted stock awards	31		429
Habu acquisition consideration holdback	2,439		2,439
Employee stock purchase plan	748		871
Directors stock-based compensation	585		625
Total non-cash stock-based compensation included in the condensed consolidated statements of operations	45,927		57,053
Less expense related to liability-based equity awards	(2,483)		(2,427)
Total non-cash stock-based compensation included in the condensed consolidated statements of equity	$	43,444	$	54,626

Schedule of Effect of Stock-based Compensation Expense on Income, by Financial Statement Line Item

The effect of stock-based compensation expense on operations, by financial statement line item, was (dollars in thousands):

	For the six months ended
	September 30,
	2025		2024
Cost of revenue	$	2,993	$	3,095
Research and development	14,835		21,125
Sales and marketing	11,483		14,476
General and administrative	16,616		18,357
Total non-cash stock-based compensation included in the condensed consolidated statements of operations	$	45,927	$	57,053

Schedule of Share-based Compensation Arrangement by Share Based Payment Award, Future Expense

The following table provides the expected future expense for all of the Company's outstanding equity awards at September 30, 2025, by award type. The amount for fiscal 2026 represents the remaining six months ending March 31, 2026. All other periods represent fiscal years ending March 31 (dollars in thousands):

	For the years ending March 31,
	2026		2027		2028		2029		Total
Stock options	$	944	$	1,075	$	95	$	—	$	2,114
Restricted stock units	32,603		54,575		28,341		2,800		118,319
Habu restricted stock awards	13		6		—		—		19
Habu acquisition consideration holdback	2,440		4,067		—		—		6,507
Employee stock purchase plan	227		—		—		—		227
Expected future expense	$	36,227	$	59,723	$	28,436	$	2,800	$	127,186

Schedule of Option Activity

Stock options activity for the six months ended September 30, 2025 was:

				Weighted-average
		Weighted-average		remaining	Aggregate
	Number of	exercise price		contractual term	Intrinsic value
	shares	per share		(in years)	(in thousands)
Outstanding at March 31, 2025	370,596	$	13.20
Exercised	(234,661)	$	15.45		$	3,263
Forfeited or canceled	(5,412)	$	9.61
Outstanding at September 30, 2025	130,523	$	9.32	7.0	$	2,326
Exercisable at September 30, 2025	58,399	$	8.96	6.5	$	1,061

Schedule of Stock Options Outstanding and Exercisable

A summary of stock options outstanding and exercisable as of September 30, 2025 was:

					Options outstanding				Options exercisable
Range of						Weighted-average	Weighted-average			Weighted-average
exercise price					Options	remaining	exercise price		Options	exercise price
per share					outstanding	contractual life	per share		exercisable	per share
$	1.20	—	$	9.99	128,813	7.0 years	$	9.16	56,689	$	8.59
$	10.00	—	$	19.99	—	0.0 years	$	—	—	$	—
$	20.00	—	$	24.99	1,710	0.7 years	$	21.32	1,710	$	21.32
					130,523	7.0 years	$	9.32	58,399	$	8.96

Schedule of Changes in Restricted Stock

Habu restricted stock share activity for the six months ended September 30, 2025 was:

		Weighted average
		fair value per		Weighted average
	Number	share at grant		remaining contractual
	of shares	date		term (in years)
Unvested restricted stock awards at March 31, 2025	1,568	$	39.48	0.7
Vested	(1,090)	$	39.48
Unvested restricted stock awards at September 30, 2025	478	$	39.48	0.8

Schedule of Time-vesting Restricted Stock Unit Activity

RSU activity for the six months ended September 30, 2025 was:

		Weighted-average
		fair value per		Weighted-average
	Number	share at grant		remaining contractual
	of shares	date		term (in years)
Outstanding at March 31, 2025	2,985,522	$	32.27	1.76
Granted	1,971,321	$	29.52
Vested	(1,296,462)	$	31.78
Forfeited or canceled	(171,109)	$	31.60
Outstanding at September 30, 2025	3,489,272	$	30.93	2.16

Schedule of Non-vested Performance-based Restricted Stock Units Activity

PSU activity for the six months ended September 30, 2025 was:

		Weighted-average
		fair value per		Weighted-average
	Number	share at grant		remaining contractual
	of shares	date		term (in years)
Outstanding at March 31, 2025	1,395,426	$	31.36	1.13
Granted	485,579	$	33.20
Vested	(332,745)	$	25.87
Forfeited or canceled	(126,546)	$	28.95
Outstanding at September 30, 2025	1,421,714	$	33.49	1.52